Adthyza
Total Payments
$21,561
Transactions
1,201
Doctors
927
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $21,561 | 1,201 | 927 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,561 | 1,201 | 100.0% |
Ad
Manufacturing Companies
- Azurity Pharmaceuticals, Inc. $21,561
Product Information
- Type Drug
- Total Payments $21,561
- Total Doctors 927
- Transactions 1,201
About Adthyza
Adthyza is a drug associated with $21,561 in payments to 927 healthcare providers, recorded across 1,201 transactions in the CMS Open Payments database. The primary manufacturer is Azurity Pharmaceuticals, Inc..
Payment data is available from 2023 to 2023. In 2023, $21,561 was paid across 1,201 transactions to 927 doctors.
The most common payment nature for Adthyza is "Food and Beverage" ($21,561, 100.0% of total).